Pre-medication regimen showed an infusion-related reaction rate of 22.5 percent with intravenous RYBREVANT®, a three-fold reduction from 67.4 percent historically seen with standard IRR management SAN DIEGO, CA – Johnson… Read More
Investment in new plant meets increasing demand for functional excipients for oral drug delivery Full integration into existing Evonik production network improves supply security and delivery times Darmstadt as a… Read More
CONSTELLA is the first and only Health Canada-approved prescription therapy for functional constipation in this patient population Submission is based on positive Phase 3 study data demonstrating linaclotide (72mcg) resulted… Read More
By Amy Chen RICHMOND, BC – The British Columbia Institute of Technology (BCIT) and the Canadian Alliance for Skills and Training in Life Sciences (CASTL), in partnership with the Province of BC and… Read More
VANCOUVER, BC – Sonic Incytes Medical Corp, a leader in point-of-care ultrasound, proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Velacur® Determined… Read More
